Thrombospondin-2 plays a protective role in multistep carcinogenesis: A novel host anti-tumor defense mechanism

EMBO Journal

Volumn 20, Issue 11, 2001, Pages 2631-2640

  Hawighorst, Thomas ^a   Velasco, Paula ^a   Streit, Michael ^a   Hong, Young Kwon ^a   Kyriakides, Themis R ^b   Brown, Lawrence F ^c   Bornstein, Paul ^b   Detmar, Michael ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Cancer; Skin; Thrombospondin 2

Indexed keywords

ANGIOGENESIS INHIBITOR; THROMBOSPONDIN; THROMBOSPONDIN 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; PAPILLOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REGULATORY MECHANISM; SKIN CARCINOGENESIS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CELL ADHESION MOLECULES; CELL DIVISION; DISEASE SUSCEPTIBILITY; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOKINES; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PAPILLOMA; PRECANCEROUS CONDITIONS; SKIN; SKIN NEOPLASMS; THROMBOSPONDINS; TIME FACTORS; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035355471     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.11.2631     Document Type: Article

References (54)

1. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2
2. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
3. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
4. Angiogenesis is an early event in the development of chemically induced skin tumors
5. Thrombospondin 2, a matricellular protein with diverse functions
6. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
7. Molecular mediators of angiogenesis in bladder cancer
8. Chymase and tryptase in dog mastocytoma cells: Asynchronous expression as revealed by enzyme cytochemical staining
9. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
10. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
11. Endothelial cell-to-cell junctions
12. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
13. Multistage carcinogenesis in mouse skin
14. Matrix metallo-proteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
15. The role of vascular endothelial growth factor in pathological angiogenesis
16. The role of angiogenesis in tumor growth
17. Hyperplasia, hyperkeratosis and benign tumor production in transgenic mice by a targeted v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia
18. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
19. The hallmarks of cancer
20. Transgenic mouse models of tumour angiogenesis: The angiogenic switch, its molecular controls and prospects for preclinical therapeutic models
21. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
22. Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumors
23. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro
24. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
25. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
26. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density and a bleeding diathesis
27. The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice
28. Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity
29. Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene
30. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels
31. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development
32. The functions of thrombospondin-1 and -2
33. The chloroacetate esterase reaction. A useful means of histological diagnosis of hematological disorders from paraffin sections of skin
34. Identification of a major keratinocyte cell envelope protein, loricrin
35. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
36. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity
37. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
38. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
39. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer
40. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth
41. Vasostatin, a calreticulin fragment, inhibits angio-genesis and suppresses tumor growth
42. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis
43. Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1
44. Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
45. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human squamous cell carcinomas
46. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice
47. Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate
48. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer
49. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
50. Inhibition of angiogenesis by thrombospondin-2
51. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1
52. Monoclonal antibody analysis of keratin expression in epidermal diseases: A 48- and 56-kDalton keratin as molecular markers for hyperproliferative keratinocytes
53. Matricellular proteins as modulators of cell-matrix interactions: Adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2
54. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines